Gravitas Life Sciences Overview

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 2

Gravitas Life Sciences General Information

Description

Manufacturer of pharmaceutical products designed for the treatment of rare liver conditions and opioid exposure. The company's technology utilizes a proprietary transmucosal buccal film to deliver drugs orally, enabling military personnel and chemical incident responders to receive temporary prophylaxis against respiratory and nervous system depression.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • NJ
  • United States
Primary Industry
Pharmaceuticals
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • NJ
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Gravitas Life Sciences Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Gravitas Life Sciences‘s full profile, request access.

Request a free trial

Gravitas Life Sciences Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Gravitas Life Sciences‘s full profile, request access.

Request a free trial

Gravitas Life Sciences FAQs

  • Where is Gravitas Life Sciences headquartered?

    Gravitas Life Sciences is headquartered in NJ.

  • What industry is Gravitas Life Sciences in?

    Gravitas Life Sciences’s primary industry is Pharmaceuticals.

  • Is Gravitas Life Sciences a private or public company?

    Gravitas Life Sciences is a Private company.

  • What is Gravitas Life Sciences’s current revenue?

    The current revenue for Gravitas Life Sciences is .

  • Who are Gravitas Life Sciences’s investors?

    Canton Strategic Holdings and Gravitas Collective have invested in Gravitas Life Sciences.

  • When was Gravitas Life Sciences acquired?

    Gravitas Life Sciences was acquired on 06-Oct-2026.

  • Who acquired Gravitas Life Sciences?

    Gravitas Life Sciences was acquired by Hepion Pharmaceuticals.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process